Why the study?
Does surgical aortic valve replacement with RESILIA tissue aortic bio-prosthesis provide safe and effective outcomes in patients requiring SAVR?
Does surgical aortic valve replacement with RESILIA tissue aortic bio-prosthesis provide safe and effective outcomes in patients requiring SAVR?
The RESILIA tissue aortic valve bioprosthesis demonstrated safety and excellent haemodynamic performance at one year post-surgical aortic valve replacement.
No takes yet. Share an insight, caveat, or question.
Short-term data support RESILIA aortic bioprosthesis safety; leaves open long-term SVD durability versus conventional valves.
Bartuś et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: